Derm Topics

Current and Emerging Management Strategies for Vitiligo
vitiligoVitiligo is an autoimmune skin disease that affects >3 million individuals in the US and around 74 million worldwide. In addition to physical symptoms such as itch, it can be particularly cosmetically concerning and psychologically distressing. It mainly affects young individuals, where it is estimated that 50% of cases have onset before the age of 20. Importantly, it is associated with other a …
vitiligo
Permanent Hair Removal for Gender Minority Individuals
What are the unique indications for permanent hair removal in gender minorities? For transgender women and other gender minority people seeking a more feminine and/or androgynous appearance, the use of feminizing hormone therapy (e.g. estrogen + finasteride/spironolactone) does not fully eliminate facial and body hair.1  Many transwomen indicate the face as the most important body part for gend …
Melanoma – Friday Pop Quiz 6/26
melanoma This 32-year-old man has two sisters each with melanoma, and his father died from metastatic pancreatic cancer. You suspect a germline mutation in which of the following genes? A. BAP1 B. TERT C. MITF D. CDKN2A E. PTCH To find out the correct answer and read the explanation, click here. Brought to you by our brand partner Derm In-Review.  A product of SanovaWorks. …
melanoma
What’s New on the Vitiligo Treatment Horizon
New Vitiligo TreatmentsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. John Harris, Vice-Chair of Dermatology and Director of the Vitiligo Clinic and Research Center at UMass Medical School in Worcester, Massachusetts, on new vitiligo treatments in the horizon. Watch as he shares recent discoveries that have influenced the way that we diagnose and manage pat …
New Vitiligo Treatments
Trifarotene for Acne Vulgaris Therapeutic Cheat Sheet
Trifarotene for acne vulgarisAcne vulgaris is one of the most common reasons for visiting the dermatologist. Topical retinoids are a mainstay of and considered first-line treatment, but patients often face issues with tolerability, which can impact adherence to therapy. We continue our series, Therapeutic Cheat Sheet, with a closer look at the recently FDA approved trifarotene. [caption id="attachment_10430" align="alignle …
Trifarotene for acne vulgaris